ArticleFrontiers in pharmacology2024

Preclinical pharmacokinetic characterization of amdizalisib, a novel PI3Kδ inhibitor for the treatment of hematological malignancies.

Shuwen Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.